Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3055291879;91880;91881 chr2:178550184;178550183;178550182chr2:179414911;179414910;179414909
N2AB2891186956;86957;86958 chr2:178550184;178550183;178550182chr2:179414911;179414910;179414909
N2A2798484175;84176;84177 chr2:178550184;178550183;178550182chr2:179414911;179414910;179414909
N2B2148764684;64685;64686 chr2:178550184;178550183;178550182chr2:179414911;179414910;179414909
Novex-12161265059;65060;65061 chr2:178550184;178550183;178550182chr2:179414911;179414910;179414909
Novex-22167965260;65261;65262 chr2:178550184;178550183;178550182chr2:179414911;179414910;179414909
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGA
  • RefSeq wild type template codon: CCT
  • Domain: Ig-149
  • Domain position: 21
  • Structural Position: 40
  • Q(SASA): 0.3643
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/V None None 1.0 D 0.804 0.797 0.939761731016 gnomAD-4.0.0 1.20032E-06 None None None None I None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.8671 likely_pathogenic 0.8423 pathogenic -0.347 Destabilizing 1.0 D 0.762 deleterious D 0.55835733 None None I
G/C 0.9806 likely_pathogenic 0.9749 pathogenic -0.805 Destabilizing 1.0 D 0.769 deleterious None None None None I
G/D 0.9954 likely_pathogenic 0.995 pathogenic -1.045 Destabilizing 1.0 D 0.825 deleterious None None None None I
G/E 0.9968 likely_pathogenic 0.9963 pathogenic -1.198 Destabilizing 1.0 D 0.815 deleterious D 0.636668257 None None I
G/F 0.9984 likely_pathogenic 0.9981 pathogenic -1.041 Destabilizing 1.0 D 0.805 deleterious None None None None I
G/H 0.9993 likely_pathogenic 0.999 pathogenic -0.745 Destabilizing 1.0 D 0.773 deleterious None None None None I
G/I 0.9967 likely_pathogenic 0.996 pathogenic -0.437 Destabilizing 1.0 D 0.81 deleterious None None None None I
G/K 0.999 likely_pathogenic 0.9988 pathogenic -1.138 Destabilizing 1.0 D 0.817 deleterious None None None None I
G/L 0.9972 likely_pathogenic 0.9965 pathogenic -0.437 Destabilizing 1.0 D 0.811 deleterious None None None None I
G/M 0.9983 likely_pathogenic 0.9979 pathogenic -0.503 Destabilizing 1.0 D 0.765 deleterious None None None None I
G/N 0.9975 likely_pathogenic 0.9968 pathogenic -0.666 Destabilizing 1.0 D 0.807 deleterious None None None None I
G/P 0.9995 likely_pathogenic 0.9995 pathogenic -0.373 Destabilizing 1.0 D 0.826 deleterious None None None None I
G/Q 0.9983 likely_pathogenic 0.9979 pathogenic -0.964 Destabilizing 1.0 D 0.827 deleterious None None None None I
G/R 0.9971 likely_pathogenic 0.9968 pathogenic -0.649 Destabilizing 1.0 D 0.832 deleterious D 0.656320095 None None I
G/S 0.9395 likely_pathogenic 0.9134 pathogenic -0.719 Destabilizing 1.0 D 0.799 deleterious None None None None I
G/T 0.9925 likely_pathogenic 0.9892 pathogenic -0.82 Destabilizing 1.0 D 0.809 deleterious None None None None I
G/V 0.991 likely_pathogenic 0.9894 pathogenic -0.373 Destabilizing 1.0 D 0.804 deleterious D 0.640300734 None None I
G/W 0.9974 likely_pathogenic 0.9973 pathogenic -1.243 Destabilizing 1.0 D 0.775 deleterious None None None None I
G/Y 0.9978 likely_pathogenic 0.9974 pathogenic -0.906 Destabilizing 1.0 D 0.798 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.